VivoSim Labs, Inc. (VIVS) support and resistance · P/E 0.7, rev $131.0K
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
This page maps VivoSim Labs, Inc. (VIVS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
VIVS currently screens at market cap $3.5M and trailing P/E 0.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VIVS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VIVS quote page for the session range and the stock page for the full model.
Not investment advice.